Le Lézard
Classified in: Covid-19 virus

The Worldwide Ophthalmic Drug Delivery System Industry is Expected to Reach $30 Billion by 2031 - ResearchAndMarkets.com


The "Global Ophthalmic Drug Delivery System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

The global ophthalmic drug delivery system market will reach $ 30,013.7 million by 2031, growing by 6.9% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population.

Companies Mentioned

This report is based on a comprehensive research of the entire global ophthalmic drug delivery system market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global ophthalmic drug delivery system market in every aspect of the classification from perspectives of Product, Dosage Form, Disease, Setting, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Based on Dosage Form, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

By Disease, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

By Setting, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Geographically, the following regions together with the listed national/local markets are fully investigated:

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Dosage Form and Setting over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

For more information about this report visit https://www.researchandmarkets.com/r/gliwbq


These press releases may also interest you

at 07:10
Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage biopharmaceutical company, announced today that enrollment for the Phase I clinical study of BAT2022 has been completed, showing that BAT2022 is well-tolerated and there were no DLT observed...

at 07:10
SES AI Corporation ("SES" or the "Company") significantly advanced its plans to produce next-generation batteries, securing support from the government of South Korea toward SES's development of Li-Metal batteries that are designed to greatly...

at 07:10
Endava plc ("Endava" or the "Company") a global provider of digital transformation, agile development and intelligent automation services, today announced results for the three months ended June 30, 2022, the fourth quarter of its 2022 fiscal year...

at 07:06
Avient Corporation , a leading provider of specialized and...

at 07:05
AVROBIO, Inc. , a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that it will present new preclinical data on novel assays used to evaluate lentiviral vector safety at the 29th...

at 07:05
10Fold, a leading integrated communications agency, today announced the availability of a new report: The Role of Content in 2022 for Tech Marketing, which revealed that 76% of companies are at least doubling their content development efforts...



News published on 10 august 2022 at 06:05 and distributed by: